Moneycontrol PRO

Sansaar

HomeNewsIndian generics

Indian Generics

Jump to

Drug shortage in US at all-time high: Does it mean great times ahead for Indian generics makers?

The scarcity of several medications in the US presents Indian pharma players with a great chance to expand market share, regulatory hurdles and industry dynamics allowing.
Border tax counter productive for US, may never happen: Strides

Going forward, the pharma company is going to to focus on its B2C business and the high cash generating verticals, he says.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347